Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
MEDH.0007.RECENTLY CAME OUT OF THE EXPERT MARKET.THEY NEED TO FILE Q1 AND Q2,TO BECOME CURRENT PINK OTC.ON WATCH,WE COULD SEE HUGE RUNS,IF THAT IDIOT CEO PLAYS HIS CARDS RIGHT.
JNSH.0026.DIRT LOW BOTTOM.PROFITABLE.CAP $825K.UNREAL.LOW O/S,AND ZERO DILUTION FOR YEARS.
THE STOCK SHOULD BE TRADING IN THE CENTS AREA IMO.CAP SHOULD BE IN THE $12 MILLION AREA OR .038 PPS.
THAT IS 4X TIMES EARNINGS OF 2024.WHEN VOLUMES RETURN THIS THING WILL HIT CENTS AGAIN.
I CAN ADD A COUPLE MILLION IN THE LOW 02S IF ANYONE WANTS OUT.LET ME KNOW.SO I CAN BRING MY HIGH AVERAGE DOWN A LITTLE.
O/S 317 MILLION.
THE LIABILITIES ARE DOWN.
Total Liabilities DOWN TO $98,942.50 FROM $ 246,475.33
Net Income $145,573.16
Cash at end of period $150,872.78
THEY MANAGED TO HAVE Q1 AND Q2 PROFITABLE.
RJDG.011s.FROM CALL OF .0051.I CALLED IT MANY TIMES.AND IT WILL BE GOING HIGHER.IMO.
ORCA
Member Level
Re: ORCA post# 24644
Thursday, November 02, 2023 11:28:20 AM
Post#
24645
of 24660
RJDG.0051.THE BEST FUNDAMENTAL,AND MOST UNDERVALUED STOCK ON THE PLANET.EVER.READ WHY.
1)MARKET CAP OF $1,9 MILLION. WITH REVENUES FOR $5,019,239.IF WE SHOULD TRADE 4X REVENUES LIKE CAP OF AROUND $20 MILLION OR .055 PPS.
2)Net Income of $642,678.00 DIVIDE THAT TO AROUND 360 MILLION O/S=.0018 PER SHARE.AT A 15 P/E=.0267 PPS.OR A LOW P/E OF 10 =.018 PPS.
3)CASH IN THE BANK $819,724
4) PER REPORT:::We are finding initial success monetizing our assets to increase shareholder value. With acquisition efforts starting to complete, we see a possible 50% or greater growth in 2024.”
5)The Company has monthly recurring revenues of $418,269 with $2,455,631 in assets, liabilities of $334,039 as of August 31, 2023.
6)2023 Net Profits were 25.4% greater than 2022
7)Backlog for revenues is greater than $1,640,000 as of August 31, 2023
8)FLOAT AROUND 110 MILLION.
BSTK.01.A SLEEPER.MADE PROFIT ON Q2.72,5 MILLION O/S.ONLY.THE IDEAL MERGER STOCK.BIG TIME.THE BEST IMO.
IF VOLUMES COME IN THIS THING.I WILL SEE .20 WITH A BLINK OF AN EYE.RED BELOW WHY.ALL THE WAY DOWN.
https://www.otcmarkets.com/otcapi/company/financial-report/407265/content
March 31, 2024 June 30, 2024
Sales $ 28,873 $ 39,784
Net (Loss) $ (6,047) $ 6,817
THE ABSOLUTE BEST STOCK IN THE PENNY MARKET FOR A MERGER.READ DD UNREAL.
FLOAT ONLY 15,5 MILLION THE REST IS OWNED MY INSIDERS.READ DD.A MERGER WILL MAKE THIS GO WILD
Market Cap Market Cap
815,464
08/30/2024
Authorized Shares
400,000,000
09/02/2024
Outstanding Shares
72,550,144
09/02/2024
Restricted
56,964,373
09/02/2024
Unrestricted
15,585,771
09/02/2024
APALS® have five issued US Utility Patents as well as International with others pending that cover the microcircuit design
and platform as well as multiple registered trademarks.
The IP portfolio is valued at $2.5M-$3M not including pending patents on Bug-Strike® and UV-Mask-Strike™
The company has sales direct to consumer via our website and Amazon Marketplace as well as sales to the US military
and NATO countries and works with ADS for DLA/TLS military sales, FBI, State and Regional Law Enforcement, Galls,
Southern Police, Grainger for both municipal and commercial entities. Spearpoint for Australia and New Zealand,
Karriomore UK and EU. Consumer sales are though Amazon sold and shipped by Amazon, Zoro, Walmart.com and
others. The company has OEM co-branded partnerships in place where it strategically makes sense with the top players
in the sector. One example of this is a co-branded OEM partnership with Pro-Troll Fishing that has wide international
distribution at the major big box retailers such as Walmart, Bass-Pro/Cabela’s, Big Rock Sports Wholesale, Worldwide
Wholesale. These wholesale and retail venues require service at the wholesale and retail store level that our
wholesale/distributor partners can provide.
New Business Opportunities:
We continue to increase visibility via social media and low-cost sponsorship opportunities. For
2024 we will be looking for new OEM partners and increasing our social media presence.
Our largest OEM customer in the fishing market recently placed a $20,000 order for APALS based on significant demand
due to numerous wins of major fishing tournaments using our APALS light. There is always a lag when innovative
technology is introduced to consumers.
$EBYH news out today
https://finance.yahoo.com/news/strainsforpains-ebyh-ceo-simon-shainberg-100000188.html
What is the new partnership announced by Strainsforpains (EBYH)?
Strainsforpains (EBYH) has signed a strategic product commercialization agreement with Cannabis Science for international retail and wholesale cannabinoid drug distribution.
What are the projected sales for Strainsforpains (EBYH) in 2024?
Strainsforpains (EBYH) projects to surpass $500,000 in sales for 2024, based on recent orders and expanding partnerships.
What key products are included in the Strainsforpains (EBYH) and Cannabis Science partnership?
The partnership includes Cannabis Science's Harvard Award-winning cancer research and CBN patent for sleep and neurological disorders, as well as Strainsforpains' existing CBD product line.
How much in orders has Strainsforpains (EBYH) received recently?
Strainsforpains (EBYH) has received orders totaling $195,000, with $65,000 in Q4 2023 and $130,000 in early 2024.
$RDAR RAADR Inc. Protecting Our Kids Online!
$EBYH Strainsforpains reporting 136k revenues first quarter! last 4 months it has booked 200k. They will be dramatically increasing in sales when they go national. CBD relief for pain.
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.otcmarkets.com/otcapi/company/financial-report/403167/content
chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.otcmarkets.com/otcapi/company/dns/news/document/73922/content
NEW YORK, April 15, 2024 (E-Buy Homes, Inc. DBA/Strainsforpains, Inc.) (OTC Markets: EBYH)
Strainsforpains, Inc. released its annual report, showing
increased sales of 1000% from $7400 in 2022 to $84,000 in 2023.
First quarter 2024 shows $130,000 in orders. I expect over 1 million in 2024 sales for the CBD division alone. The management is showcasing its products and services at numerous shows this year ( Benzinga Miami, Javits Center NYC, etc.)
$CBMJ's Patriot.TV Adds Sam Sorbo to Prime-Time Host Revolutionizing the Media Landscape with New Platform Launch
https://www.otcmarkets.com/stock/CBMJ/news/CBMJs-PatriotTV-Adds-Sam-Sorbo-to-Prime-Time-Host-Revolutionizing-the-Media-Landscape-with-New-Platform-Launch?id=432541
VENICE, FL / ACCESSWIRE / March 6, 2024 / Conservative Broadcast Media & Journalism (CBMJ) is pleased to announce that it has launched their groundbreaking media broadcast platform Patriot.TV. Additionally, Patriot.TV has added renowned education freedom advocate Sam Sorbo to its Prime-Time host lineup.
The Sam Sorbo Show along with a growing lineup of A-List shows can be viewed at www.patriot.tv
On Friday, March 1, 2024, Patriot.TV unveiled its state-of-the-art website, marking a significant milestone in the evolution of media consumption.
President and COO Brannon Howse articulated the innovative features and purpose behind the new Patriot.TV website. "Patriot.TV is, by design, your one-stop media shop for talk television, talk radio, and news and information articles. This easy-to-navigate website is the first launch of a multimedia network that will include a Roku Channel, Google Chrome, Amazon Fire Channel, and App for push notifications. These platforms will not only allow our audience to watch our exclusive programming for free, but after thirty days, our programs will roll behind our paywall for our subscribers to access on their schedule."
In addition to the website launch, on March 4, 2024, Patriot.TV unveiled the debut of the new prime time show hosted by Sam Sorbo. An advocate for education freedom, Sam Sorbo's mission is to empower parents and children to emancipate themselves from the confines of the modern school system. With a successful background as a Hollywood film actress, writer, and producer, Sam brings a wealth of experience and insight to her role.
When asked why she joined Patriot.TV, Sam was quick to respond:
"As an Education Freedom Advocate, I'm thrilled to join a platform that understands our fight for freedom, faith, and family. We cannot preserve freedom without truth, and truth is what Patriot.TV is all about. The main reason I joined Patriot.TV is the leadership of General Flynn and Brannon Howse who inspire and encourage me to do more, reach higher, and go deeper in the pursuit of truth. If courage had a face, it would look just like those men."
Brannon Howse expressed his excitement about adding Sam Sorbo to Patriot.TV, describing it as the realization of an idea conceived three years ago.
"I met Sam Sorbo when I interviewed her at my news desk on live television during CPAC three years ago in Florida. I knew then that between her incredible wisdom, class, on-camera presence, and experience, she needed her own prime-time show. Once I came on board at Patriot.TV, I knew this was the time to make this happen. I am very pleased Sam has chosen to join our incredible lineup of gifted communicators and hosts. Our audience will benefit greatly from the truth she will present."
Patriot.TV's new platform and Sam Sorbo's prime-time show represent a significant step forward in delivering informative, engaging, and empowering content to viewers. With a commitment to truth and freedom, Patriot.TV continues to redefine the media landscape.
About Patriot.TV
Patriot.TV is a leading media broadcast platform dedicated to providing cutting-edge, informative content across television, radio, and online platforms. With a focus on truth, freedom, and empowering narratives, Patriot.TV is at the forefront of shaping the future of media consumption. Visit www.patriot.tv for more information.
About CBMJ: (OTC PINK:CBMJ) Conservative Broadcast Media and Journalism is a media and web-based Patriot Company.
CONTACT:
Mark Schaftlein
877-704-6773
SOURCE: Conservative Broadcast Media & Journalism, Inc.
$CBMJ
Watch Live: https://patriot.tv/
$EBYH NEWS......... Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.
https://finance.yahoo.com/news/strainsforpains-ceo-simon-shainberg-discusses-120000687.html
$EBYH NEWS......... Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.
https://finance.yahoo.com/news/strainsforpains-ceo-simon-shainberg-discusses-120000687.html
ETrade has had that for years...........
Z
HUGE NEWS FOR DAY TRADERS SCHWAB.READ.WOW.THIS IS AMAZING.MORE FLIPPING FOR FLIPPERS.MORE CHICKEN TRIOS.
The trade settlement period will be shortened to one day beginning May 28, 2024.
Trades executed on or after May 28, 2024 will settle on the next business day (T+1) for most U.S. and Canadian securities traded on U.S. exchanges. Currently, the settlement period is two business days after the trade date (T+2).
New shortened settlement period reduces risk.
This is an industry-wide change for most security transactions, which includes stocks, bonds, municipal securities, exchange-traded products, unit investment trusts, certain mutual funds and limited partnerships that trade on an exchange. The T+1 settlement period may benefit investors like you by reducing credit and liquidity risks present between the trade date and the settlement date.
Your next steps.
$KLGDF think gold in 2024 https://kingworldnews.com/gold-very-close-to-another-major-breakout-as-we-head-into-2024/
$LQWC Revolutionizing Wastewater Treatment:
LifeQuest World Corp. (OTC:LQWC)
Imagine a World Where Water is the New Gold...
That world is closer than you think. With water scarcity becoming a pressing global issue, the demand for efficient wastewater treatment is skyrocketing. Enter LifeQuest World Corp. - your next big opportunity in the multi-billion-dollar wastewater treatment space.
💲$BLEG .0015 Money flowing into BLEG...Follow the Money!
RJDG.0051.THE BEST FUNDAMENTAL,AND MOST UNDERVALUED STOCK ON THE PLANET.EVER.READ WHY.
1)MARKET CAP OF $1,9 MILLION. WITH REVENUES FOR $5,019,239.IF WE SHOULD TRADE 4X REVENUES LIKE CAP OF AROUND $20 MILLION OR .055 PPS.
2)Net Income of $642,678.00 DIVIDE THAT TO AROUND 360 MILLION O/S=.0018 PER SHARE.AT A 15 P/E=.0267 PPS.OR A LOW P/E OF 10 =.018 PPS.
3)CASH IN THE BANK $819,724
4) PER REPORT:::We are finding initial success monetizing our assets to increase shareholder value. With acquisition efforts starting to complete, we see a possible 50% or greater growth in 2024.”
5)The Company has monthly recurring revenues of $418,269 with $2,455,631 in assets, liabilities of $334,039 as of August 31, 2023.
6)2023 Net Profits were 25.4% greater than 2022
7)Backlog for revenues is greater than $1,640,000 as of August 31, 2023
8)FLOAT AROUND 110 MILLION.
JNSH.0038.HUGE REPORT OUT. REVENUES $ 2,25 M.Net Income $578,710.34
Total SHARE HOLDER Equity $1,465,707.54 DIVIDE TO O/S OF 317,239,161=BOOK VALUE OF .0046 PER SHARE.WE ARE TRADING BELOW BOOK VALUE.LOL
THE NET INCOME OF $578,710.34 DIVIDE TO 317,239.161 SHARES IN THE O/S=.00182 PPS EARNINGS.AT A MULTIPLE OF 15=.0273 PPS.AND AT A MULTIPLE OF 10=.018 PPS IS WHERE IT SHOULD BE TRADED MINIMUM.
THE STOCK IS RIDICULOUSLY UNDERVALUED.
REPORT ON THE LINK.
https://www.otcmarkets.com/otcapi/company/financial-report/378351/content
$AESO New_Merger_Play_Here ~ Targets .10/.25 For Starters🚀
DD Thread below.
$AESO Will be a Spin Out Merger of $AESO and NASDAQ Stock $RCRT We are getting in on the ground floor here before the RCRT merger completes and assets put into ASEO https://t.co/gAmIDtUdux (RCRT) filed 8K to purchase $AESO$AESO DD Below click this post.
— 💸 Golden Cross Stocks 💸 (@CrossStocks) August 3, 2023
RJDG.0056. EVALUATION:)))))A MUST READ:TREMENDOUSLY UNDERVALUED.
1)WILL HAVE AROUND $5,1 MILLION IN REVENUES FOR 2023 ENDING NEXT MONTH.AND Backlog for Silex Holdings is currently greater than $2,400,000 as of May 31, 2023
2)NET PROFIT OF AROUND $730,000.00 AND DIVIDE THAT TO 359 MILLION FROM THE O/S =.002 PER SHARE IN NET INCOME.AT A 15 P/E=SHOULD BE TRADING IN THE .03 PPS MINIMUM.TH STOCK IS ENORMOUSLY UNDERVALUED.
3)CASH IN THE BANK ALREADY OVER $800,000.00.
4)The Company has monthly recurring revenues of $415,254
5)$2,454,695 in assets
6)liabilities ONLY. $454,007
7)shareholder equity of $2,000,659 as of May 31, 2023.OR BOOK VALUE OF .0056.
8)ZERO DILUTION WITH A FLOT ONLY AROUND 105 MILLION.
9)Outstanding Shares 359,357,992 07/21/2023 Restricted 133,794,969 07/21/2023
Unrestricted 225,563,023 07/21/2023 Float 104,832,488 01/18/2023
10)THE STOCK SHOULD BE TRADING AT AROUND .03 MINIMUM IMO.LOOK AT THE NUMBERS BELOW.LAST PR.
Ron Brewer, CEO of RJD Green (RJDG.NaE), said: "Our results shows that as of May 31, 2023, for the third quarter, we are on course for over $5,000,000 annual revenue with 10.5% net operating profit; through Quarter Three $3,652,371 in Revenue and Net Operating Profit of $521,815, with cash and cash equivalents of $803,988 as of May 31, 2023. We are focused on finding ways to monetize our assets and increase shareholder value fully. RJD is currently very actively engaged in acquisition efforts that are symmetric with our current operations and bring immediate and long-term growth. We look forward to seeing the fruit of our efforts by completing one or more of these opportunities.
“RJD Green revenue projections for the Fiscal Year ending August 31, 2023, are $5,100,000 with an expected Net Operating Profit of $727,250.”
Financial Results of the Third Quarter for Fiscal Year August 31, 2023.
The Company had year to date Revenue of $3,652,371 and a Net Operating Profit of $521,815 with cash and cash equivalents of $803,988 as of May 31, 2023.
The Company has monthly recurring revenues of $415,254 with $2,454,695 in assets, liabilities of $454,007 and shareholder equity of $2,000,659 as of May 31, 2023.
Financial Notes
Revenues have increased annually since the merger of RJG Green accompanied with annual profit growth each year.
Backlog for Silex Holdings is currently greater than $2,400,000 as of May 31, 2023, and IOSoft Inc. has diversified its software platforms to reach more diverse markets.
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
https://www.barrons.com/articles/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-eaa82e6d?mod=md_stockoverview_news
$ODYY hearing big things here. Big run coming
$KRTL ~ KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp.
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
https://www.barrons.com/articles/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-eaa82e6d?mod=md_stockoverview_news
$KRTL Seven Cipher’s robust vulnerability assessment and management solutions, along with compliance standards such as ISO, NIST, GDPR, SOC2, and others, will ensure a multi-layered security and compliance approach for KRTL's operations. This partnership will enhance KRTL's ability to safeguard its client’s Web2 and Web3 environments from future threats, including AI-assisted intrusions and eventual quantum-based attacks.
https://www.barrons.com/articles/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions-eaa82e6d?mod=md_stockoverview_news
$KRTL and $MMMW are undervalued penny stocks.
***AI***-STOCK-PLAY-***AI***-NEWS-https://www.nasdaq.com/press-release/spo-global-inc.-adopts-initiative-to-implement-artificial-intelligence-ai-in-its-food
***AI***LOW-FLOAT-UNDERVALUED-PLAY -https://www.otcmarkets.com/stock/SPOM/security
WOW $SPOM $2,000,000 IN CASH-https://www.nasdaq.com/press-release/spo-global-inc.-announces-strong-1st-quarter-financial-operations-and-performance
$KRTL ~ KRTL Holding Group Inc. operates its wholly owned subsidiaries, KRTL Biotech, Inc. and KRTL International Corp.
$KRTL In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
https://www.morningstar.com/news/globe-newswire/8847936/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions
$KRTL In a strategic move to bolster its cybersecurity capabilities in support of their MedTech expansion, KRTL Biotech has also entered into a channel partner agreement with boutique cybersecurity firm, Seven Cipher Group LLC ("Seven Cipher"). Seven Cipher combines industry-leading technology and methodology to provide comprehensive cloud and endpoint security solutions. Their innovative approach includes AI, machine learning, and behavioral analytics for proactive threat detection and management.
https://www.morningstar.com/news/globe-newswire/8847936/krtl-partnered-to-bring-comprehensive-cloud-and-endpoint-security-and-ai-powered-telemedicine-solutions
$KRTL Bryant Thornton, CEO of Seven Cipher, recognizes the significance of this alliance. "Our partnership with KRTL Biotech signals the accessibility and attainability of enterprise-level cybersecurity at a small and medium business level in the alternative wellness industry and beyond. With our combined expertise, we are well-positioned to tackle the unique challenges of this rapidly evolving digital landscape."
"Our partnership with Seven Cipher is crucial in our commitment to provide secure and reliable services in our MedTech efforts alongside solutions like Medflow. As we continue to innovate in our industry, the security of our operations and the privacy of our clients and partners remain a top priority." KRTL Biotech’s CEO, Daniel Ball added.
$HMBL In addition to the investment made by Pacific Lion in HUMBL, the company will also be working with Pacific Lion, a firm that specializes in delivering strategic direct investments and hands-on advisory services to help with the growth of early stage companies. The firm focuses on strategies that help capitalize public companies via retail and institutional investors, along with crowdfunding, equity lines and M+A consulting, with the goal of direct uplistings to a major exchange over a 6-18 month targeted time frame.
“We believe that HUMBL has developed an early-mover advantage in providing Web 3 digital wallets, products and services to consumer and government clients,” said Jacob Fernane, CEO of Pacific Lion. “We believe our access to strategic funding, share structure cleanup, technology and operations augmentation, and more, will allow HUMBL to scale to the levels needed for a major exchange uplist and to rejuvenate its powerful retail shareholder base.”
$HMBL HUMBL Selected as Official Digital Wallet and Ticketing Technology Provider for “Motherland Samoa 2023” Festival
https://finance.yahoo.com/news/humbl-selected-official-digital-wallet-185500287.html
$HMBL In addition to the investment made by Pacific Lion in HUMBL, the company will also be working with Pacific Lion, a firm that specializes in delivering strategic direct investments and hands-on advisory services to help with the growth of early stage companies. The firm focuses on strategies that help capitalize public companies via retail and institutional investors, along with crowdfunding, equity lines and M+A consulting, with the goal of direct uplistings to a major exchange over a 6-18 month targeted time frame.
“We believe that HUMBL has developed an early-mover advantage in providing Web 3 digital wallets, products and services to consumer and government clients,” said Jacob Fernane, CEO of Pacific Lion. “We believe our access to strategic funding, share structure cleanup, technology and operations augmentation, and more, will allow HUMBL to scale to the levels needed for a major exchange uplist and to rejuvenate its powerful retail shareholder base.”
$HMBL Another funding strategy the company intends to employ is to file an offering under Regulation A+. Regulation A+ allows companies to raise money under two different tiers. Fully reporting SEC reporting companies such as HUMBL are able to raise up to $75,000,000 on a Tier 2 offering in any 12-month period from the general public. The company hopes to attract a new shareholder base that uses the HUMBL technology and would like to help fund the company directly.
The company will continue in its efforts to secure additional funding and reduce debt in preparation for its attempts to uplist to a major exchange in the future.
READ BOLD.IF YOUR COMPANY TRADES IN EXPERT MARKET AND WANTS TO GET RELISTED
What Is the OTC Markets Expert Market? Securities Lawyer Blog
Most of the companies quoted on OTC Markets are not able to meet the minimum listing requirements for trading on a national securities exchange. Many of these companies do not file periodic reports or audited financial statements with the SEC, making it difficult for the public to find current, reliable information about those companies. Companies quoted on the OTC Markets are divided into four tiers, the OTCQX, the OTCQB, the OTC Pink and the Expert Market. Companies on the Expert Market provide the lowest level of disclosure in comparison to other OTC Market tiers. As a result, trading is limited to quotation on an unsolicited basis.
On October 15, OTC Markets reported that “2,247 former Pink No Information securities shifted to the Expert Market tier, where securities may only be quoted on an Unsolicited (customer order) basis. Quotes of securities in the Expert Market are “Unsolicited Only,” which means that trades of securities subject to unsolicited quotation in the Expert Market are only available to broker-dealers, institutions and other sophisticated investors, and not average investors.
The SEC’s amendments to Rule 15c2-11 became effective on September 28, 2021. Amended Rule 15c2-11 eliminated broker-dealer quotes of securities of issuers that fail to make current information publicly available. With the amendments to Rule 15c2-11, the OTC Markets Group Expert Market became the platform for broker-dealers to publish unsolicited quotes of securities designated as “No Information” securities. Typically, these are companies not subject to or not in compliance with SEC public company reporting requirements.
Because of the restrictions imposed on securities quoted on the Expert Market, most investors will not be able to publicly sell their shares. Additionally, they will not have access to bid and ask prices or other information, including trading volume. As such, Expert Market shares are illiquid.
Companies moved to the Expert Market from another OTC Markets tier can apply to relist on the OTC Pink or other OTC Markets tier by becoming an SEC reporting company, submitting a new Form 211, and meeting OTC Markets requirements for the particular tier.
Hamilton & Associates Law Group can assist companies on the Expert Market with uplisting to other OTC Market tiers. For further information, please contact Brenda Hamilton, Securities Attorney, at 200 E. Palmetto Park Rd, Suite 103, Boca Raton, Florida, (561) 416-8956, by email info@securitieslawyer101.com or visit www.securitieslawyer101.com.
This securities law blog post is provided as a general informational service to clients and friends of Hamilton & Associates Law Group and should not be construed as and does not constitute legal advice on any specific matter, nor does this message create an attorney-client relationship. Please note that the prior results discussed herein do not guarantee similar outcomes.
Hamilton & Associates | Securities Lawyers
Brenda Hamilton, Securities Attorney
200 E. Palmetto Park, Suite 103
Boca Raton, Florida 33432
$EMED Matthew Wolfson, Founder and CEO commented, "Q4 was a breakout quarter. We saw topline sales jump in response to further expansion in our brand awareness and sales & marketing performance. Overall, it was our best quarter since we went public and provides strong market feedback that our next-generation R&D and market positioning represents the start of an exciting new chapter for Electromedical. And the path is only going to get more exciting as we get ready to launch our revolutionary Infinity device."
$AVOI New Play_Change_of_Control Monday - Debt free...Still Early
New owner: JJW Investments, Debbie Rasmussen, Debt free...still early...
8K: https://www.otcmarkets.com/filing/html?id=16580399&guid=tFm-ka3VoTiqJth
$EMED Electromedical’s commitment to create long-lasting drug-free solutions to pain management is honored by the development of The WellnessPro Plus®, a technologically advanced TENS (transcutaneous electrical nerve stimulation) therapy device focusing on pain relief.
$EMED With over a million frequencies to choose from, WellnessPro Plus® offers the widest frequency range on the market allowing it to have numerous applications. FDA CLEARED, it features a “future-ready” modular design, making it widely adaptable to new accessories and therapies.
$EMED Matthew Wolfson, Founder and CEO commented, "Q4 was a breakout quarter. We saw topline sales jump in response to further expansion in our brand awareness and sales & marketing performance. Overall, it was our best quarter since we went public and provides strong market feedback that our next-generation R&D and market positioning represents the start of an exciting new chapter for Electromedical. And the path is only going to get more exciting as we get ready to launch our revolutionary Infinity device."
$EMED Matthew Wolfson, Founder and CEO commented, "Q4 was a breakout quarter. We saw topline sales jump in response to further expansion in our brand awareness and sales & marketing performance. Overall, it was our best quarter since we went public and provides strong market feedback that our next-generation R&D and market positioning represents the start of an exciting new chapter for Electromedical. And the path is only going to get more exciting as we get ready to launch our revolutionary Infinity device."
GMER.028.ON DECEMBER 20TH IT WAS CALLED AT .031.ON FEBRUARY 9TH IT HIT .05S.I AM WATCHING NOW AGAIN TO GET A GOOD POSITION ON IT.SOON.
|Feb 09 2023 0.044755 -0.00095 -2.08% 0.048 0.0505 0.0443 560,297
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170746377
ORCA
Member Level
Re: poincianamike post# 24593
Tuesday, December 20, 2022 2:53:25 PM
Post#
24595
of 24617
I CAN NOT WAIT.GMER.031.WILL GO BANANAS IN 2023.IMO.
AMMX.43X.51.WAS CALLED NOVEMBER 23RD 2022 AT .34.ONE TO WATCH BIG TIME.READ DD BELOW WHY.
ORCA
Member Level
Re: None
Wednesday, November 23, 2022 11:11:52 AM
Post#
24589
of 24616
AMMX.34.A MUST READ .10 PER SHARE INCOME,FOR THE 9 MONTHS.UNREAL.AND .06 PER SHARE FOR Q3.CRAZY NUMBERS.
SHOULD BE TRADING IN $3.00 PER SHARE.
Profit from operations rose significantly to $2.2 million for the nine-month period, compared to profit from operations of
$1.6 million for the comparable 2021 nine-month period.
Net income for the nine-month period rose 171 percent to $1.4 million when compared to net income of $526,570 for the
comparable nine-month period.
Earnings per share (EPS) were $0.10 for the period compared to EPS of $0.04 for the comparable 2021 nine-month period.
Balance Sheet for the Nine-Month Period Ended September 30, 2022
Total Assets were $14.3 million, a $4.5 million increase due in part to an increase of accounts receivable and inventory.
https://www.otcmarkets.com/otcapi/company/financial-report/352903/content
For Immediate Release
AmeraMex International Reports Financial Results for Its Third Quarter Ended
September 30, 2022
CHICO, CA – November 23, 2022 – AmeraMex International, Inc. (OTCQB:AMMX), a provider of heavy equipment for logistics
companies, infrastructure construction, and forestry conservation, reported financial results for its third quarter ended
September 30, 2022.
CEO Lee Hamre commented, “2022 has been a great year for revenue and net income. This is due in part to product mix, and
cost containment measures which have significantly increased our profit margins. We are also pleased that the addition of
new product lines and refocusing on the construction industry are beginning to pay off. We are fortunate to sell into multiple
markets – from logistics to agriculture, manufacturing, and construction.
“I would like to add that I am pleased with what we accomplished in the third quarter. All though there remains a nationwide
shortage of truck drivers and costs for materials and fuel remain high, our team has and will continue to focus on controlling
costs and improving profit margins.
“Instead of having a conference call to discuss what are now stale numbers during the Thanksgiving holiday, I will be hosting
a conference call in December to discuss the year end and what we expect 2023 to look like. If you have questions regarding
the third quarter results, please contact CFO, Hope Stone, or board member, Marty Tullio,” added Hamre.
Statement of Operations for the Quarter Ended September 30, 2022
The Company reported revenue of approximately $7.5 million versus revenue of $8.2 million for the comparable 2021
quarter, a nine percent decrease.
Gross profit for the quarter was $2.5 million, compared to gross profit of $815,261 for the comparable 2021 quarter. This is
a 211 percent increase.
Gross profit as a percentage of sales, was 35 percent for the quarter compared to gross profit, as a percentage of sales, of 10
percent for the comparable 2021 quarter.
Profit from operations rose significantly to $1.7 million for the quarter, compared to profit from operations of $343,132 for
the comparable 2021 quarter
Net income for the quarter was $928,850 compared to net income of $82,691 for the comparable 2021 quarter. Prices of
equipment have been adjusted to cover increased cost of goods sold and operating costs.
Earnings per share (EPS) were $0.06 for the quarter compared to EPS of $0.01 for the comparable 2021 quarter.
Statement of Operations for the Nine-Month period September 30, 2022
The company reported revenue of approximately $14.8 million versus revenue of $18.9 million for the comparable 2021
period, a 20 percent decrease. Revenue for 2021 was the highest in the Company’s history due, in part, to pent-up demand
for equipment created the COVID-19 pandemic.
Gross profit for the period was $4.2 million compared to gross profit of $3.0 million for the comparable 2021 period. This is
an increase of 45 percent.
Gross profit, as a percentage of sales, was 29 percent for the period compared to gross profit, as a percentage of sales, of 16
percent for the comparable period.
2
Profit from operations rose significantly to $2.2 million for the nine-month period, compared to profit from operations of
$1.6 million for the comparable 2021 nine-month period.
Net income for the nine-month period rose 171 percent to $1.4 million when compared to net income of $526,570 for the
comparable nine-month period.
Earnings per share (EPS) were $0.10 for the period compared to EPS of $0.04 for the comparable 2021 nine-month period.
Balance Sheet for the Nine-Month Period Ended September 30, 2022
Total Assets were $14.3 million, a $4.5 million increase due in part to an increase of accounts receivable and inventory.
BSTK.022.WAS CALLED NOV 8TH 2022 AT .015.NOW IS TRADING IN THE .022 AREA,ONE TO WATCH PROFITABLE COMPANY.
ORCA
Member Level
Re: None
Tuesday, November 08, 2022 3:26:29 PM
Post#
24585
of 24615
BSTK.015.THEY REPORTED NET INCOME FOR Q3.THE STOCK IS BIG TIME UNDERVALUED.READ BELOW.THIS IS ONE OF THE CLEANEST COMPANIES OUT THERE.IF THEY DO A MERGER.IT WILL HIT $1.00 PPS.
THE REASON IS??READ BELOW WHY.
https://www.otcmarkets.com/otcapi/company/financial-report/348150/content
1) REVENUES FOR Q3 $ 72,435
2)Net Income FOR Q3 $ 24,260.22
3)Net cash increase for period $ 1,924.10
Cash at beginning of period 9,889.52
4)Cash at end of period $ 11,813.62
5)FLOAT ONLY 15,5 MILLION.AS INSIDERS OWN THE REST OF THE O/S
6)ZERO DILUTION.
7)CAP ONLY $1,1 MILLION.
8)THE STOCK SHOULD BE TRADING IN THE .07S MINIMUM IMO.
BSTK SECURITY DETAILS
Share Structure
Market Cap Market Cap
1,197,077
11/07/2022
Authorized Shares
400,000,000
11/07/2022
Outstanding Shares
72,550,144
11/07/2022
Restricted
56,964,373
11/07/2022
Unrestricted
15,585,771
11/07/2022
BLLB.0021.WAS CALLED AT .0016 NOVEMBER 2ND 2022.ON FEBRUARY 13TH
IT ROCKED TO .0034 HIGH=MORE THAN 100% MOVE,
I AM STILL A SHAREHOLDER,AND WAITING TO SEE WHAT HAPPENS
Feb 13 2023 0.0025 0.00 0.0% 0.0027 0.0034 0.002 16,978,166
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170351905
ORCA
Member Level
Re: None
Wednesday, November 02, 2022 1:46:31 PM
Post#
24584
of 24614
BLLB .0016.ALERT COMPLETE EVALUATION FROM ORCA.READ THE Q3 REPORT.WHY IS THE PPS EXTREMELY UNDERVALUED??READ BELOW
1)Revenue $ 773,945 FOR THE Q3 VS ZERO REVENUES FROM A YEAR AGO=TREMENDOUS PROGRESS
2)Net Income$ 124,744 $ FOR THE Q3 VS A LOSS $(43,656) A YEAR AGO Q3=HUGE PROGRESS.
3)Cash – beginning of period $280 ONLY. VS NOW Cash – end of period $ 471,775=TREMENDOUS PROGRESS.
4)Total Stockholders’ equity POSITIVE $1,291,425 VS MINUS (123,642)
HUGE PROGRESS.= BOOK VALUE AROUND .0016 PER SHARE.
5)Total Liabilities ONLY $48,899 VS $ 910,085 LAST YEAR.=HUGE PROGRESS.
6)CAP ONLY $1,3 MILLION=AS MUCH AS THE BOOK VALUE.LOL.
THE PRICE PER SHARE SHOULD BE TRADING AT 4 TIMES REVENUES AROUND $3 MILLION OR .0038 PPS MINIMUM.AND THAT IS ONLY WITH THE Q3 REVENUES.LOL.
7)ZERO DILUTION.
SS UPDATED BELOW NO CHANGE.
Market Cap Market Cap
1,328,037
11/01/2022
Outstanding Shares
830,023,254
11/01/2022
$PVSP Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.
https://www.morningstar.com/news/globe-newswire/8730826/pervasip-announces-artizen-spin-off
$GBHL
PHOTO BELOW TAKING IN 2015:)
ALERT TO NEWBIES AND OTHER TRADERS.READ FIRST LINK BELOW BEFORE YOU INVEST IN PENNY STOCKS.
PLEASE READ THE WHOLE INBOX..........THANK YOU AND WELCOME ON THIS BOARD.
FIRST LINK BELOW PLEASE READ THE DISCLOSURE.YOU WILL LIKE IT.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=40547468
LOOKING FOR UNDERVALUE PENNY STOCKS,THAT CAN MAKE US SEVERAL BAGGERS.%%%%%%%%%%%%%%%%%.PLEASE PROVIDE SOME DD WHEN YOU POST THEM AS TO WHY YOU THINK THEY ARE UNDERVALUED.
DD LIKE SHARES A/S, O/S, FLOAT,EARNINGS,REVENUES,CAP OF COMPANY,
FORWARD LOOKING EVENTS,FUTURE REVENUES AND EARNINGS,CDs,DILUTIONS ETC.
NO JUST DROPING SYMBOLS AND SAY:THIS GOING TO GO, OR THIS IS AN EASY DOUBLE,ETC.
ALSO PREFERABLY THE STOCKS THAT ARE UNDERVALUE AT BOTTOM PRICES,OR NEAR THE BOTTOM,OR WHEN THEY JUST STARTING TO MAKE A MINI MOVE.
WE DO NOT WANT TO GET KILLED BY BUYING THE TOPS.LOL.
THE PHOTO BELOW IS THE "SPEED DANCER" WITH MY HALLOWEEN COSTUME,
OCTOBER 31ST 2015.AT HOME, BEFORE GOING OUT FOR HALLOWEEN NIGHT AT THE CLUBS:)
TRADERS,READ THIS CAREFULLY.THIS IS THE BEST JOB IN THE WORLD.NEEDS A LOT OF TIME AND DEVOTION.
BUT IT COULD BE LIFE TIME DREAM.IMAGINE BE ON YOUR OWN HOME GET UP HAVE A NICE BREAKFAST TURN ON YOUR PCs AND READY TO KICK ASS.YOU DO NOT HAVE TO DRIVE ANY PLACE. OR HAVE ANY BOSS ON TOP OF YOUR HEAD.YOU CAN TAKE YOUR LAPTOP AND DO IT FROM ANY PLACE IN THE WORLD.THAT COULD BE YOUR DREAM BUD COME TRUE.
AND REMEMBER IF SOMEONE EVER TELLS YOU TRADING IS CASINO LAUGH AT THEM.
DIFFERENCES ARE=THERE ARE TWO IMPORTANT DISTICTIONS TO RECOGNIZE WHEN COMPARING TRADING TO THE GAMBLING AT THE CASINO.THE FIRST DISTICTION IS THAT THE MARKETS ARE OPEN.YOU ARE NOT TRADING AGAINST THE HOUSE,LIKE IN THE CASINO.YOU ARE TRADING AGAINST OTHER TRADERS.
THE SECOND DISTINCTION IS THAT YOU CAN DEVELOP YOUR OWN STATISTICAL EDGE.
IF YOU CAN DEVELOP A STATISTICAL EDGE YOU WILL DO MUCH BETTER TRADING.
I HAVE DEVELOP MY OWN STATISTICAL EDGE.CAME BY STUDYING LEVEL II,COUNTLESS HOURS,TRY TO UNDERSTAND WHAT THE OTHER TRADERS,OR MMs TRYING TO DO BEFORE THEY MAKE A MOVE.
AND USING TOOLS TO BEAT THEM ON THEIR GAME.BEFORE THEY BEAT ME.LOL.
CASINOS HAVE THEIR OWN STATISTICAL EDGE=THEY TAKE YOUR MONEY.YOU HAVE NO CONTROL OVER THE HOUSE.EVEN IF SOME PEOPLE WIN SOMETIMES,IF THEY STAY IN THERE LONG PERIOD OF TIME,THEY WILL GIVE IT ALL BACK AND LOSE SOME OF THEIR OWN TOO.I HOPE YOU UNDERSTAND WHAT I AM TRYING TO TELL YOU.
DISCLAIMER
Trading strategies discussed on this board are often high risk and not suitable for everyone. If you are losing money in the market, you may wish to seek the advice of a licensed securities professional. No one is responsible for your gains or losses in the market except YOU . If you follow any stocks strategies discussed on this board you may LOSE ALL YOUR MONEY. Please weigh the strategies discussed here carefully against what you are willing to risk. By posting or reading this board you are accepting the sole responsibility for your own investment decisions.
IN MY 19 YEARS OF TRADING HAVE NEVER TOLD ANYONE TO BUY ANY STOCK.I DO NOT GIVE ADVICES.I DO NOT SEND OUT BUY RECO VIA E-MAILS OR WHAT EVER OTHER WAY.
Please do your own due diligence before buying or selling ANY SECURITY.No one is responsible for your gains or losses in the market except YOU. Opinions expressed on this board are just that. Opinions. I am not a licensed broker.
NEW VIDEOS BELOW FEBRUARY 28-2103.TAKIS 51 YEARS OLD, POSING BICEP AND TRICEP ON THE ONE VIDEO,AND THE OTHER JUST BICEP FLEXING.BOTH NICE VIDEOS.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |